Elevated Liver Enzymes at the Time of Deceased Donor Organ Donation Do Not Affect Recipient or Pancreas Allograft Survival Following Pancreas Transplantation
HPB(2024)
摘要
Background
There is a lack of data on the impact of donor liver function tests (LFTs) on pancreas transplantation outcomes. Understanding their contribution could expand the donor pool.
Methods
Using the UNOS database, data from January 2010 - 2022 was retrospectively analyzed. Multivariable cox regressions were performed to evaluate the association between LFTs (AST, ALT and total bilirubin levels), graft failure and mortality up to three years post-transplant.
Results
9,138 pancreas transplants were completed. Multivariate analysis showed no association between donor AST values > 500 U/L and increased rates of graft failure (p =0.826) or mortality (p =0.836). Similar findings were noted for donor ALT values > 500 U/L (p = 0.522 and p =0.997 , respectively). There was no correlation with graft failure (p =0.322 ) or mortality (p= 0.423 ) for total bilirubin levels > 3 mg/dL.
Discussion
LFTs in the deceased pancreas donor did not increase risk of graft failure or mortality following pancreas transplantation. Elevated LFTs should not serve as absolute contraindications to transplant.
更多查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要